Intensity Therapeutics, Inc. (INTS) stock
INTSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.28+0.19 (+6.15%)
Close on Nov 11, 2026Market cap $10.71MP/E –Yield –
Intensity Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Intensity Therapeutics's enterprise value was $455.97K on Nov 3, 2026, against $12.49M a year earlier. Over the last 4 years it ranged from $216.12K to $101.84M, with a median of $18.19M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 3, 2026 | $455.97K | -96.5% |
| 2025 | Dec 31, 2025 | $13.03M | -39.7% |
| 2024 | Dec 31, 2024 | $21.62M | -78.8% |
| 2023 | Dec 29, 2023 | $101.84M | – |
See a number that looks wrong?